Bank of America Corporation »

Peregrine Pharmaceuticals shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.1M 478k 6.50
2023-09-30 $3.2M 339k 9.44
2023-06-30 $3.5M 252k 13.97
2023-03-31 $8.2M 436k 18.76
2022-12-31 $6.5M 469k 13.77
2022-06-30 $3.0M 199k 15.27
2021-12-31 $7.5M 256k 29.18
2021-06-30 $2.0M 79k 25.64
2021-03-31 $1.2M 64k 18.23
2020-12-31 $267k 23k 11.55
2020-09-30 $131k 17k 7.62
2020-06-30 $131k 20k 6.59
2020-03-31 $112k 22k 5.10
2019-12-31 $164k 21k 7.70
2019-09-30 $139k 26k 5.33
2019-03-31 $47k 11k 4.26
2018-12-31 $140k 34k 4.08
2018-06-30 $17k 4.2k 4.02
2018-03-31 $41k 14k 2.90